Using orlistat to inhibit FASN activity in B16-F10 mouse melanoma cells triggers the intrinsic apoptosis pathway, characterized by cytochrome c release and the activation of caspase-9 and -3, and it is accompanied by increased ROS production and elevated cytosolic calcium levels [78]. Here, FASN is linked to melanoma.